nippon.com·2 min read·medium
Long-Term Safety of iPS Spinal Cord Therapy Confirmed in Japan
✦AI Summary
Researchers at Japan's Keio University have confirmed the long-term safety of iPS cell-derived neural progenitor cell transplants in patients with spinal cord injuries. No major safety issues or tumor formations were observed in patients two to four years post-surgery.
Tokyo, July 21 (Jiji Press)--Long-term safety has been confirmed after neural progenitor cells derived from induced pluripotent stem, or iPS, cells, were transplanted into patients with spinal cord injuries, a team of researchers at Japan's Keio University said Tuesday.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in